<DOC>
	<DOCNO>NCT00450216</DOCNO>
	<brief_summary>The purpose study evaluate whether HZT-501 effective reduce rate development ibuprofen-associated ulcer patient require long-term daily use ibuprofen .</brief_summary>
	<brief_title>Efficacy Safety Study HZT-501 Subjects Requiring Nonsteroidal Anti-Inflammatory Drug ( NSAID ) Treatment</brief_title>
	<detailed_description>HZT-501 combination product include ibuprofen acid reduce agent famotidine . The study design determine whether combination product reduce rate ulcer development subject require long-term daily use ibuprofen . Subjects assign randomly , approximately 2:1 ratio , treatment either HZT-501 ( ibuprofen 800 mg/famotidine 26.6 mg ) ibuprofen ( 800 mg ) three time daily 24 week treatment period develop either endoscopically-diagnosed upper gastrointestinal ulcer and/or prohibitive toxicity . Subjects visit study center Screening Weeks 4 , 8 , 16 , 24 . Physical exam perform , clinical laboratory measurement make , select time study . Endoscopic exams perform Screening Weeks 8 , 16 , 24 . Subjects contact four week follow study completion .</detailed_description>
	<mesh_term>Famotidine</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>Expected require daily administration NSAID least come six month condition osteoarthritis , rheumatoid arthritis , chronic low back pain , chronic regional pain syndrome , chronic soft tissue pain . Did use NSAID within 30 day prior study entry History erosive esophagitis History follow serious gastrointestinal complication : perforation ulcer , gastric outlet obstruction due ulcer , gastrointestinal bleeding . Active cardiac , renal , and/or hepatic disease Current Helicobacter pylorus ( H. pylorus ) infection Use acid suppressant agent , misoprostol , 325 mg/day aspirin within 14 day prior study entry . Uncontrolled diabetes Uncontrolled hypertension Positive pregnancy test screen Positive test Screening human immunodeficiency virus ( HIV ) , hepatitis B , hepatitis C. Currently participate , participation within 30 day prior study entry , investigational drug study Please note additional criterion . The study center determine patient meet criterion .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>ibuprofen</keyword>
	<keyword>famotidine</keyword>
	<keyword>ulcer</keyword>
	<keyword>NSAIDS</keyword>
	<keyword>pain</keyword>
	<keyword>arthritis</keyword>
	<keyword>chronic regional pain syndrome</keyword>
	<keyword>chronic soft tissue pain</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>rheumatoid arthritis</keyword>
	<keyword>chronic low back pain</keyword>
</DOC>